Acumen Pharmaceuticals, Inc. ABOS
2.24
0.00
0.00%
as of 25 Sep
- Market cap
- $161.6M
- P/E
- 0.0×
Follow ABOS
| Dec '17 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | 0.00 | 0.00 | — | — | — | — | — |
P/S ratio |
— | 6.05 | 6.05 | — | — | — | — | — |
P/FCF ratio |
— | 0.00 | 0.00 | — | — | — | — | — |
P/Operating CF |
— | (2.04) | (2.04) | — | — | — | — | — |
P/B ratio |
— | 0.00 | 0.00 | — | — | — | — | — |
Price to Tangible BV |
— | 0.00 | 0.00 | — | — | — | — | — |
EV/Sales |
— | (41.87) | (41.87) | — | — | — | — | — |
EV/EBITDA |
— | 5.43 | 5.43 | — | — | — | — | — |
EV/Operating CF |
— | 5.58 | 5.58 | — | — | — | — | — |
EV/FCF |
— | 5.58 | 5.58 | — | — | — | — | — |
Quick Ratio |
— | 8.60 | 46.00 | 37.74 | 22.73 | 18.77 | 6.21 | 3.89 |
Current Ratio |
— | 9.38 | 46.57 | 38.60 | 23.08 | 19.01 | 6.46 | 4.07 |
Net Debt/EBITDA |
— | 0.84 | 5.53 | 10.00 | 3.98 | 3.33 | 1.20 | 0.69 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.05% | 9.64% | 12.31% | 25.37% |
Debt/Equity |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.11 | 0.16 | 0.44 |
Asset Turnover |
— | 0.46 | 0.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
— | 0.89 | 1.02 | 0.18 | 0.82 | 0.82 | 0.84 | 0.95 |
Capex/Depreciation |
— | — | — | (0.25) | (0.25) | 0.01 | 0.00 | 0.14 |
Interest Coverage |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| — | 51.22% | 48.82% | (97.40%) | (20.71%) | (22.98%) | (45.60%) | (96.20%) | |
| — | (209.94%) | (28.31%) | (73.23%) | (20.08%) | (20.67%) | (37.27%) | (67.07%) | |
ROIC |
— | 0.00% | 0.00% | (39.55%) | (250.76%) | (71.63%) | (179.60%) | 0.00% |
Return on Tangible Assets |
— | (119.85%) | (16.85%) | (51.98%) | (24.82%) | (22.40%) | (67.90%) | (131.54%) |
Average Days of Receivables |
— | 6.45 | 27.71 | — | — | — | — | — |
Research and Development Expense of Revenue |
— | 505.36% | 556.89% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
— | 54.57% | 94.08% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
— | 10.25% | 10.72% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
— | (12.49) | (12.49) | — | — | — | — | — |
Graham Number |
— | 0.00 | 132.11 | — | — | — | — | — |
Earnings Yield |
— | (1,065.13%) | (1,065.13%) | — | — | — | — | — |
Free Cash Flow Yield |
— | (124.08%) | (124.08%) | — | — | — | — | — |
Revenue per Share |
— | 3.94 | 3.43 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
— | (15.83) | (17.78) | (0.90) | (0.87) | (0.89) | (1.44) | (1.91) |
Capex per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
— | (15.83) | (17.78) | (0.90) | (0.87) | (0.89) | (1.44) | (1.91) |
Cash per Share |
— | 15.21 | 104.48 | 9.68 | 4.37 | 5.01 | 2.86 | 1.93 |
Shareholders Equity per Share |
— | (26.51) | (44.37) | 11.23 | 4.65 | 5.49 | 3.03 | 1.16 |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | (26.51) | (44.37) | 11.23 | 4.65 | 5.49 | 3.03 | 1.16 |
Free Cash Flow |
— | (6.82) | (7.45) | (18.00) | (35.31) | (43.08) | (86.23) | (115.63) |
Working Capital |
— | 6.41 | 43.48 | 193.51 | 172.52 | 233.64 | 150.70 | 92.25 |
Capital Expenditures |
— | — | — | (0.04) | (0.16) | (0.02) | (0.02) | (0.09) |
Net Current Asset Value |
— | (11.56) | (18.59) | 193.51 | 172.52 | 203.46 | 121.13 | 69.85 |
EV/EBIT |
— | 5.43 | 5.43 | — | — | — | — | — |
Capex to Sales |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Profit Margin |
— | (452.92%) | (510.10%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Price to Operating Income |
— | 0.00 | 0.00 | — | — | — | — | — |
| Other line items | ||||||||
Depreciation/Fixed assets |
— | — | — | 4.42 | 3.98 | (24.07) | 0.00 | 0.00 |
Cash ROIC |
— | 140.06% | (29.58%) | (4.29%) | (9.64%) | (7.99%) | (22.52%) | (52.89%) |
Accounts Receivable Turnover |
— | 24.42 | 20.66 | — | — | — | — | — |
Accounts Payable Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | — | — | — |
Average Receivables |
— | 0.07 | 0.07 | — | — | — | — | — |
Average Payables |
— | 0.38 | 0.38 | 0.81 | 1.36 | 1.51 | 3.51 | 3.10 |
Average Assets |
— | 3.66 | 25.88 | 137.38 | 213.46 | 253.36 | 274.56 | 180.91 |
Average Common Equity |
— | (15.01) | (15.01) | 103.30 | 206.98 | 227.87 | 224.39 | 126.12 |
Columns are period end dates